WESTCHESTER COUNTY BIOSCIENCES UPDATE |
|
Featuring news, events and industry trends |
|
Cayuga Biotech Appoints New CEO
Mount Vernon-based Cayuga Biotech, an early-stage platform biotechnology company harnessing biomimetic polyphosphate to address severe bleeding and wound healing, announced that Andrea Ashford-Hicks has been named the company’s Chief Executive Officer (CEO). Ms. Ashford-Hicks, who brings more than 20 years of industry experience, will succeed Damien Kudela, PhD, the inventor of lead candidate CAY001 and co-founder of Cayuga Biotech, who will assume the role of Chief Scientific Officer.
Prior to Cayuga, Ms. Ashford-Hicks served as Senior Vice President of Late-Stage Development and Commercialization at Enzyvant Therapeutics. Under her leadership, Enzyvant received FDA approval for RETHYMIC® for pediatric congenital athymia. She also has contributed to multiple regulatory approvals and product launches over her career in leadership roles at Agenus, EMD Serono, Janssen, Allos, and Pfizer. Ms. Ashford-Hicks earned a dual degree in Biology from the University of Pennsylvania’s Wharton school and College of Arts and Sciences.
|
|
Teladoc Health and Amazon Team Up to Launch
Teladoc on Alexa
Purchase-headquartered Teladoc Health, the global leader in whole-person virtual care, announced a first of its kind experience with Amazon Alexa with the launch of voice-activated general medical virtual care on supported Echo devices, such as an Echo, Echo Dot, and Echo Show. Customers in the U.S. will now be able to connect with a Teladoc care provider 24/7 from supported Echo devices for general medical needs. Teladoc on Alexa will initially launch via audio with video visits coming soon.
“Teladoc Health’s collaboration with Amazon is yet another step in breaking down barriers to healthcare access,” Donna Boyer, chief product officer for Teladoc Health, said in the news release. “By introducing and integrating our virtual first care experience with Echo devices, we are providing an innovative and convenient way for users to connect with a doctor. We are meeting consumers where they are, to continue to deliver value and high-quality care to members.”
To get started, customers can say, “Alexa, I want to talk to a doctor,” to their supported Echo device to connect with the Teladoc call center.
Customers will get a call back on their Echo devices from a Teladoc doctor for virtual visits related to nonemergency health needs, such as experiencing symptoms of a cold, flu, or allergies, according to the company.
Visits covered by insurance might have no cost at all; without insurance, visits are $75.
|
|
The Argos Cardiac Output Monitor Interface is Declared Compatible with Philips IntelliBridge, Enabling Seamless Data Transfer to Hospital Electronic Medical Record (EMR) systems
Compatibility with Philips' IntelliVue and IntelliBridge systems adds to the growing list of Argos' existing EMR functionality such as Capsule Technologies and Masimo's EMR middleware. Argos customers now have more pathways to incorporate Argos' clinical data into the patient's EMR allowing hospitals to streamline workflows in both their ORs and ICUs.
|
|
Ascensia Diabetes Care Launches the Eversense Now Remote Monitoring App for Android Users In Europe
Developed by Senseonics and brought to people with diabetes by Ascensia, Eversense is the world's first and only long-term continuous glucose monitoring system. The Eversense NOW Remote Monitoring App allows real-time glucose data and alerts from Eversense users to be remotely shared with friends and family. The app allows up to five people to remotely receive updated readings approximately every five minutes, with the ability to easily view recent trends and alerts.
The Eversense NOW Remote Monitoring App is now available for both Apple and Android devices across Europe and can be downloaded via the Apple® App Store and Google Play™ Store.
|
|
Central New York Biotech Accelerator Now Accepting Applications for 2022 Medical Device Innovation Challenge
The CNYBAC Medical Device Innovation Challenge is a 6-month intensive mentorship / network expansion / resource rich program for early-stage innovators. This highly competitive program accepts 5-6 teams each year to participate. To date, 26 teams have graduated from the program and have amassed milestone achievements during and following their participation. The MDIC serves as a complement and a pipeline to other incubation/acceleration programs.
Applications are accepted January 1 through April 30 each year and are reviewed through a due diligence process performed by The Innovation Law Center, Syracuse University. Participants are selected by the MDIC Review Committee - interviews may be convened to assist in team selection. The program starts August 1 (some teams receive early commercialization research in advance of program start). You may participate virtually or on-site. If on-site, you receive 6-months of free work space in the CNYBC Creation Garage, 841 E. Fayette St., Syracuse, NY. All selected teams can utilize this facility at any point in time during the program.
|
|
Biotech & Patient Engagement: More Important Than Ever
NewYorkBIO is holding its second annual Patient Engagement Summit on April 6th, bringing together industry, advocacy organizations, and - most importantly - the patient community for a dialogue on how innovation in healthcare can be more inclusive.
April 6, 2022
9:00am to 1:00pm
Fully virtual, free event
|
|
Have good news to share from
Westchester’s biosciences ecosystem?
Please let us know.
|
|
If you would like to continue receiving this weekly newsletter,
please sign up below. If you would like to contact us directly, click the Contact Us link.
|
|
|
|
|
|
|
